PDCD1 and neoplasm: We observed significantly higher levels of exhaustion (ICOS, TIM3, CTLA4, PD1, LAG3, TIGIT) and activation (TNFSR9, CD69, CD25) markers for clonotypes restricted to the tumor (Figure 5H).